Pharmafile Logo
Pharmafocus logo
Advanced Search

Brain scanning technology to be used for clinical psychedelics trials in pioneering London start-up partnership

April 25, 2023
Business Services

London, UK: Commercial trials for psychedelics-assisted medical treatments will now have access to state-of-the-art brain scanning technology thanks to a …

News
Press release

Alchemab Therapeutics to present data profiling a novel antibody to Huntingtin Exon 1 at the CHDI Annual Huntington’s Disease Therapeutics Conference

April 25, 2023
Business Services

Cambridge, UK, April 25, 2023 – Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to …

News
Press release
national-cancer-institute-kmvohcb-w5g-unsplash_1

EMA validates marketing authorisation application for Jemperli with chemotherapy

April 25, 2023
Medical Communications

GSK has announced that the European Medicines Agency (EMA) has validated the company’s Type II Variation for a new indication …

News
testalize-me-0je8ynv4mis-unsplash

3B Pharmaceuticals and Novartis enter into licensing agreement for FAP-targeting technology

April 25, 2023
Research and Development

German biotechnology company 3B Pharmaceuticals (3BP) and Switzerland-based Novartis have announced that they have entered into a Global Exclusive Licensing …

News
hal-gatewood-_jbclosdsd4-unsplash

NICE publishes Final Appraisal Document for multiple myeloma drug

April 25, 2023
Medical Communications

The National Institute for Health and Care Excellence (NICE) has submitted a Final Appraisal Document (FAD) for the use of …

News
robina-weermeijer-so1l3jsdd3y-unsplash_2

AstraZeneca and Ionis share positive results from phase 3 trial for eplontersen

April 25, 2023
Medical Communications

AstraZeneca and Ionis have announced positive results from their phase 3 NEURO-TTRansform trial in patients with hereditary transthyretin-mediated amyloid polyneuropathy …

News

National Institute for Health and Care Excellence recommends Darzalex® (daratumumab) with bortezomib and dexamethasone for routine use on the NHS as treatment for multiple myeloma

April 24, 2023
Business Services

High Wycombe, 24 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson are pleased to announce that the …

News
Press release

Sphere Fluidics begins work with partners on 3DSecret program to investigate mechanisms of metastasis in cancer

April 24, 2023
Business Services

Cambridge, UK, 24th April 2023: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, …

News
Press release

Incyte Announces European Commission Approval of Opzelura® (ruxolitinib) Cream for the Treatment of Non-Segmental Vitiligo with Facial Involvement in Adults and Adolescents

April 24, 2023
Business Services

WILMINGTON, Del. – April 20, 2023 – Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has granted a marketing …

News
Press release

Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorisation for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations

April 24, 2023
Business Services

BEERSE, Belgium, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission …

News
Press release

NICE gives green light to ibrutinib plus venetoclax as first-line treatment option for chronic lymphocytic leukaemia

April 24, 2023
Business Services

High Wycombe, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson is pleased to announce that the …

News
Press release
national-cancer-institute-9k4fglw6efq-unsplash

NICE recommends treatment combination for advanced leukaemia

April 24, 2023
Medical Communications

The National Institute for Health and Care Excellence (NICE) has recommended Janssen’s imbruvica (ibrutinib) alongside venetoclax as a treatment option …

News
mufid-majnun-cm1au42fnrg-unsplash_3

Sanofi offers hepatitis A vaccine for UK children

April 24, 2023
Medical Communications

Sanofi has introduced a hepatitis A vaccine for children aged between one to 15 years old in the UK. The …

News
towfiqu-barbhuiya-hn2hqoalbck-unsplash_1

AbbVie shares results from phase 3 trial for atogepant migraine treatment

April 24, 2023
Research and Development

AbbVie has shared positive results from its phase 3 ELEVATE study, which assessed atogepant for the preventative treatment of episodic …

News
markus-spiske-hvsr_cvecvi-unsplash

Aptar and Healint announce collaboration on CNS and immune system conditions management

April 24, 2023
Medical Communications

AI healthcare company Healint and Software as a Medical Device (SaMD) expert Aptar Digital Health have announced a collaboration aiming …

News

RetinAI and Boehringer Ingelheim partner over AI treatments for geographic atrophy

April 21, 2023
Medical Communications

Swiss data management software company RetinAI and US-based Boehringer Ingelheim have announced a partnership to improve patient outcomes in geographic …

News

FDA awards clearance to Meridian Bioscience for Curian Shiga Toxin assay

April 21, 2023
Medical Communications

Meridian Bioscience, a US-based diagnostic testing solutions provider, has announced that the FDA has given clearance for its new Curian …

News

Breye Therapeutics Strengthens Management Team and Board

April 20, 2023
Business Services

Copenhagen, Denmark, 20 April 2023 – Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing novel oral therapies for retinal …

News
Press release
solen-feyissa-xfnfmlnpwdo-unsplash

Johnson & Johnson warns of dangers of Benadryl TikTok challenge

April 20, 2023
Medical Communications

Following the death of a 13-year-old boy who took part in an online “challenge” to take a large amount of …

News
charles-deloye-2roumsg9rnw-unsplash

Eli Lilly partners with Ivy Tech Community College for scholarship programme

April 20, 2023
Medical Communications

Eli Lilly and Ivy Tech Community College, Indiana, US, have announced a new scholarship programme, known as Lilly Scholars @ …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025